| Stewart DA, Bahis N, Mansoor A
pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Jun 26.:1-7.
Abstract | Full Citation | | Corn BW, Wang M, Fox S, et al.
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. [JOURNAL ARTICLE]
J Neurooncol 2009 Jun 16.
Abstract | Full Citation | | Affronti ML, Heery CR, Herndon JE, et al.
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. [JOURNAL ARTICLE]
Cancer 2009 Jun 9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | McNeill DR, Lam W, Deweese TL, et al.
Impairment of APE1 Function Enhances Cellular Sensitivity to Clinically Relevant Alkylators and Antimetabolites. [JOURNAL ARTICLE]
Mol Cancer Res 2009 May 26.
Abstract | Full Citation | Find Related Articles | | Arifin DY, Lee KY, Wang CH
Chemotherapeutic Drug Transport to Brain Tumor. [JOURNAL ARTICLE]
J Control Release 2009 Apr 16.
Abstract | Full Citation | Find Related Articles | | Adam Z, Veselý K, Krejcí M, et al.
[Interdigitating dendritic cell sarcoma of low extremitis resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation] [English Abstract, Journal Article]
Vnitr Lek 2009 Feb; 55(2):147-57.
Abstract | Full Citation | | Chopko BW
Intracavitary carmustine polymer implantation as an adjunct to palliative metastatic vertebral column tumors. [LETTER]
Surg Neurol 2009 Mar 27.
Full Citation | Find Related Articles | | Cui B, Johnson SP, Bullock NH, et al.
Bifunctional DNA Alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway. [JOURNAL ARTICLE]
Mol Pharmacol 2009 Mar 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Winter JN, Inwards DJ, Spies S, et al.
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
J Clin Oncol 2009 Apr 1; 27(10):1653-9.
Abstract | Full Citation | Find Related Articles | | Kyle RA, Jacobus S, Friedenberg WR, et al.
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. [JOURNAL ARTICLE]
Cancer 2009 Feb 26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
